Article
Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
Journal of the National Cancer Institute - 4 Jun 2003
Eskandarpour Malihe, Hashemi Jamileh, Kanter Lena, Ringborg Ulrik, Platz Anton, Hansson Johan
Abstract excerpt
BACKGROUND: Germline alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) are important genetic factors in familial predisposition to melanoma. Activating mutations of the NRAS proto-oncogene are among the most common somatic genetic alterations in cutaneous malignant melanomas. We investigated the occurrence of NRAS mutations in melanomas and dysplastic nevi in individuals with germline CDKN2A mutations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
